So, now it appears adding L'ville to the ACC was good thing after all.
Yep, member institutions will receive medication right after local strippers.
So, now it appears adding L'ville to the ACC was good thing after all.
We discussed this on the non-political thread, but there are major sampling and analytic issues with the paper. The issues are covered here and, if you're able to get through a lot of highly technical statistical jargon, here.
Ioannidis, as others have pointed out, is a shit stirrer in the research field and, like many shit stirrers, is a hypocrite when it comes to the specificity of his own research. One of the authors also published an op-ed without disclosing that he was an author of the study and Ioannidis and Bhattacharya have been prominent sources on conservative articles and op-eds that question stay-at-home orders and advocate for re-opening the economy.
ETA:
ETA: Bogan has a PhD in biophysics, but runs a hedge fund called Bogan Associates, LLC
I have an in-law who worked that U of C call. It has not worked on everyone. The article makes it sound like it works on a pretty high percentage. I don't know. But I was told when it works it works fast. So fast they are discharging people within a couple of days and aren't always able to get good monitoring data. Working on dosages.
More anecdotal evidence. The hospital that treated patient 1 in Washington state gave him this drug as his condition deteriorated. He improved quickly and was discharged within days of taking it. Hospital has participated in the Gilead trial ongoing it sounds like and stresses while all the data has to be assembled their anecdotal experiences say it shows promise.
I can't see any difference in Aptamers than the standard use of a monoclonal antibody especially with aptamers having even less binding affinity and strength. Id put it in the pile of press release with little substance.
You all buy this? Clearly a disgruntled employee of the Wuhan lab texted the Louisville scientists to tell them what spread formation COVID-19 is going to use next.
NY Study says 90% of those going on Vents end up dying
NY Study says 90% of those going on Vents end up dying
How much does it cost?
Its another horribly premature thing to put out. I get the need for data but incomplete data is worse than no data at all. Its like taking a Kaplan-Meir curve and just picking a random endpoint and assigning groups based off outcomes instead of pre-assigned groups and determining outcome.
Its another horribly premature thing to put out. I get the need for data but incomplete data is worse than no data at all. Its like taking a Kaplan-Meir curve and just picking a random endpoint and assigning groups based off outcomes instead of pre-assigned groups and determining outcome.
Its another horribly premature thing to put out. I get the need for data but incomplete data is worse than no data at all. Its like taking a Kaplan-Meir curve and just picking a random endpoint and assigning groups based off outcomes instead of pre-assigned groups and determining outcome.
Daily survival probability for injecting Clorox into the lungs?